Atos SE Atos operates under the brands Atos, Atos Consulting & Technology Services, Worldline, Atos Worldgrid and Atos Healthcare. From 2012 - 2015, Atos Healthcare was part of a serious controversy in the UK over Work Capability Assessment introduced in 2008 to determine who should receive employment and support allowance. Decisions were taken by officials at the DWP using evidence from the assessments carried out by Atos Healthcare.
Salesforce.com is a cloud computing company headquartered in San Francisco, California. Though its revenue comes from a customer relationship management product, Salesforce also tries capitalizing on commercial applications of social networking through acquisition. As of 2015, it is one of the most highly valued American cloud computing companies with a market capitalization of $50 billion, It is listed on the New York Stock Exchange and is a constituent of the S&P 500 index.
Sample Customers
Syntel SyntBots
FunderMax, Microsoft, University of Tasmania, Red Hat OpenShift, AdvantageCare Physicians
Chatter
Coca Cola Enterprise, Blue Shield of California, Stanley Black & Decker, Wells Fargo Bank, Phillips, Toyota Motors, American Red Cross, Time Warner Cable, Virgin America,Canon, and Bayer Pharmaceuticals.
MuleSoft RPA
1. Accenture
2. Aetna
3. Allianz
4. American Express
5. AT&T
6. Bank of America
7. Barclays
8. BNY Mellon
9. Capital One
10. Cisco
11. Coca-Cola
12. Colgate-Palmolive
13. Comcast
14. Deloitte
15. Deutsche Bank
16. DXC Technology
17. E&Y
18. FedEx
19. General Motors
20. GlaxoSmithKline
21. HSBC
22. IBM
23. Intel
24. Johnson & Johnson
25. JPMorgan Chase
26. KPMG
27. Liberty Mutual
28. Mastercard
29. McKesson
30. Merck & Co.
31.MetLife
32. Microsoft
33. Morgan Stanley
34. Nationwide
35. Nestlé
36. Nike
37. Novartis
38. Oracle
39. PepsiCo
40. Pfizer
We monitor all reviews to prevent fraudulent reviews and keep review quality high. We do not post
reviews by company employees or direct competitors. We validate each review for authenticity via cross-reference
with LinkedIn, and personal follow-up with the reviewer when necessary.